Recovering from a total knee replacement is not easy. Pain levels are often intense, mobility is limited, and most patients are sent home with a prescription for opioid medications immediately after surgery. While these medications can help, they also bring risks—side effects, such as nausea, vomiting, drowsiness, constipation besides risk for dependence, and sometimes prolonged use long after recovery.

Now imagine this:
A patient undergoes knee replacement surgery, goes home, uses a simple drug-free patch, and never needs opioids at all.

That is exactly what happened in a newly published peer-reviewed case report, where the NeuroCuple® device was used as part of post-operative care.

A major medical journal has now documented what many NeuroCuple® users already know:
A small, non-invasive nano-capacitive device may meaningfully reduce pain after surgery—without drugs, without batteries, and without side effects.

🔗 Full article (open access): https://pmc.ncbi.nlm.nih.gov/articles/PMC10519305/

What the Journal Publication Was About

This case report comes from the Department of Anesthesiology and Orthopedics at the University of Pittsburgh Medical Center. It describes one patient who underwent primary unilateral total knee arthroplasty (TKA)—one of the most painful orthopedics procedures.

After surgery, the patient was discharged home with standard instructions. However, instead of relying on opioid medications, the patient applied the NeuroCuple® device directly over the surgical dressing.

The result?

The patient never used a single opioid tablet at home but had good pain relief.

No complications.
No adverse reactions.
No breakthrough pain that required stronger medication.

For patients and clinicians alike, this is a remarkable outcome—especially given today’s need for safer, non-pharmacologic, opioid-alternative, postoperative pain solutions.

How the NeuroCuple® Device Works (Simple Version & Clinical Version)

For everyday readers:

The NeuroCuple® contains billions of tiny nano-capacitors embedded in a thin patch. When placed near an area of pain, many users feel the pain begin to “turn down,” often within minutes.

It doesn’t add anything to your body.
It doesn’t use electricity, heat, cold, or chemicals.
It simply interacts with the body’s natural electrical signals.

For clinicians:

The device uses a nano-capacitive layer engineered to alter and stabilize local electrical disturbances caused by tissue trauma and inflammation. The proposed mechanism—normalizing disrupted bioelectric fields—aligns with emerging evidence on electro-biologic modulation of pain pathways. Simply, the excessive electrical signals in injured or inflamed tissues are absorbed by the NeuroCuple’s nanoparticles and these pain electrical signals are not transmitted to the brain to perceive.

No active current.
No frequency delivery.
No exogenous energy input.

Just passive modulation of micro-electrical gradients.

Study Highlights

✔ Opioid-Free Home Recovery

Despite undergoing TKA (one of the most painful elective surgeries), the patient:

• Did not require postoperative opioid medication at home

• Managed pain effectively with the NeuroCuple® device

• Reported high satisfaction and functional stability

✔ No Side Effects or Safety Issues

• No skin irritation

• No interference with the surgical dressing

• No concerns related to electrical or thermal output

• No delayed wound healing

✔ Fast, Simple Application

The patient placed the patch over the bandage, demonstrating:

• No need for direct skin contact

• Ease of use at home

• Compatibility with standard surgical dressings

✔ Potential to Reduce Opioid Exposure

A single case report does not prove universal efficacy, but it suggests that:
Nano-capacitive technology may help select patients avoid opioid exposure at home entirely.

Why This Matters (for Patients & Clinicians)

For Patients

• Pain after knee replacement can be intense.

• Many people want to avoid opioids but don’t know what alternatives are safe or effective.

• A drug-free device such as NeuroCuple that helps reduce pain—without side effects—gives people more control over their recovery.

For individuals sensitive to medications or worried about dependence, this offers hope.

For Clinicians

This case report opens valuable discussions:

1. A Low-Risk Addition to Multimodal Analgesia

The NeuroCuple®:

• Is passive without electrical stimulation

• Has no drug–drug interactions

• Is safe and does not require monitoring

• Can be placed over dressings

• Does not interfere with cryotherapy, physical therapy, or regional anesthesia protocols

2. Opportunity for Opioid Stewardship

Given the documented risks of new persistent opioid use after TKA, even a partial reduction in postoperative opioid exposure is clinically meaningful.

3. Fits Seamlessly into ERAS Pathways

Enhanced Recovery After Surgery (ERAS) emphasizes:

• Minimizing opioid use and pain

• Early mobilization

• Patient empowerment

• Non-pharmacologic and non-opioid analgesia without adverse effects

The NeuroCuple® aligns with these goals without increasing workload.

4. Strong Safety Profile

The absence of adverse events in this report—and in broader use—is important for postoperative patients who may have:

• Fragile skin

• Multiple comorbidities

• Polypharmacy

• Sensitivity to systemic analgesics

What This Means for Future Pain Care

This single case report is not a definitive trial, but it adds to a growing body of evidence—including the randomized University of Pittsburgh Medical Center study—supporting the NeuroCuple® as a practical, effective, scalable and opioid-alternative, pain-relief solution.

Together, these studies suggest:

• Meaningful reductions in pain

• Lower opioid reliance

• Excellent patient tolerance

• Ease of clinical adoption

Larger controlled studies are already underway, including NIH-funded research.

Implications for nCAP Medical

This publication strengthens nCAP Medical’s scientific foundation in several key ways:

1. Clinical Validation

Peer-reviewed documentation of opioid-free recovery supports:

• Paitient Bennefits

• Provider confidence

• Hospital interest

• Payer conversations

• Future clinical trial design

2. Technology Leadership

The study highlights the uniqueness of nano-capacitive pain modulation—an emerging category that nCAP Medical pioneered.

3. Market Expansion

Real clinical results attract:

• Orthopedic surgeons

• Anesthesiologists

• Physical therapy groups

• Pain, primary care physicians and surgical nurse practitioners

• Post-acute rehabilitation teams

4. Momentum for Larger Studies

As evidence accumulates, the NeuroCuple® becomes stronger positioned for:

• ERAS pathway integration

• Clinical guidelines discussions

• Broader adoption

• Global health applications

Conclusion

This new case report demonstrates something extraordinary:
A non-drug, non-electrical nano-technology device helped a knee replacement patient avoid opioid use entirely after surgery.

For patients, it offers hope and reduces fear of experiencing severe pain after home discharge and helps avoid excessive opioid use and related side-effects.
For clinicians, it offers a new and effective non-opioid tool in multimodal pain management.
For nCAP Medical, it marks another milestone in advancing safe, effective, innovative and scalable pain-relief solutions.

As more studies continue and awareness grows, the NeuroCuple® stands poised to become a cornerstone in the future of drug-free postoperative care.